Cryo-Cell International, Inc. revenue for the last year amounted to 32.00 M USD, the most of which — 31.55 M USD — came from its highest performing source at the moment, Umbilical Cord Blood and Cord Tissue Stem Cell Service, the year earlier bringing 30.80 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Cryo-Cell International, Inc. 31.99 M USD, and the year before that — 31.34 M USD.